WlakeWestlake Pharma, Inc.

Your solution to China Partnerships

Westlake Pharma, Inc.
612 Corporate Way, STE 9
Suite 9
Valley Cottage, NY 10989
United States

ph: (201) 887-2495

  • Home
  • About Us
    • Our Team
    • Our Facilities
  • Products
  • Services
  • Partners
  • Contact Us

Our Team

Westlake is staffed with the most talented and competent team of scientists and technicians, who have completed and are capable of timely FDA approvals for most complex products, along with a distinguished team of scientific, regulatory and legal experts.

Dr. Yan Lou, Ph.D.

Founder and President

Pharmaceutical scientist and an entrepreneur.

More than twenty years of pharmaceutical experience, of which about 10 years is at Roche and Barr Laboratories, Inc., Mainly in the preformulation and formulation area with different kinds of dosage forms which included IR, ER ODT tablets and capsule: semisolid/liquid soft gelatin capsules: IR/ER combination tablets and capsule.
In 2001, joined Hisun, as Vice Present, she directed all technical aspects of R&D, from product development to  manufacture validation process. She accomplished Hisun’s solid plant that has passed both EMEA and TGA GMP inspection, finished five IR capsules and one ER tablets to Europe Dossier submission. All have been approved for sale in Europe.
In addition Dr. Lou is in charge of the preparation and filing of drug development and regulatory documentation or reports which includes ANDA, NDA, and similar regulatory applications for regulatory authorities in one or more countries.
Ph.D in Pharmaceutical from UIC.

Sharif Ahmed, MS

Chief Regulatory Officer

Pharmaceutical entrepreneur with 25 years of pharmaceutical idustry experience, 

Directorof Regulatory Affairs at BarrLaboratories, Inc. which became asubsidiary of Teva. Worked in awide variety of therapeuticareas, including reproductivehealth,analgesics, anesthetics,arthritis,cardiovascular, respiratory,anti-infectives, psychiatry, neurologyand oncology. 

Expertise includes solid oral, semi-solids, liquids, injectables,ophthalmics, nasal sprays andtransdermal drug deliverysystems. 

At Barr, he worked with 5developmentsites spread across US andEurope. He was also responsible forthe US regulatory group based inEurope. In addition to gettinghundreds of ANDA approved by theFDA, he managed the CMCsubmissions of the key Barr IND andNDAs. 

Master's in pharmacy and a Master's in pharmaceutical marketing and health care administration.

Copyright 2009-2017 Westlake Pharma, Inc. All rights reserved.

Web Hosting by Turbify

Westlake Pharma, Inc.
612 Corporate Way, STE 9
Suite 9
Valley Cottage, NY 10989
United States

ph: (201) 887-2495